Literature DB >> 16609139

Infliximab as a treatment for systemic amyloidosis associated with Crohn's disease.

M Iizuka, S Konno, Y Horie, H Itou, K Shindo, S Watanabe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16609139      PMCID： PMC1856134          DOI： 10.1136/gut.2005.087577

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  7 in total

1.  Crohn's disease associated with renal amyloidosis successfully treated with an elemental diet.

Authors:  Y Horie; M Chiba; K Miura; M Iizuka; O Masamune; A Komatsuda; T Ebina
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

2.  Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.

Authors:  Antonio Fernández-Nebro; Eva Tomero; Vera Ortiz-Santamaría; María Carmen Castro; Alejandro Olivé; Manuel de Haro; Rosa García Portales; Rosa García-Vicuña; María Victoria González-Mari; Armando Laffón; Rosario García-Vicuña
Journal:  Am J Med       Date:  2005-05       Impact factor: 4.965

Review 3.  Medical treatment of inflammatory bowel diseases.

Authors:  Gert Van Assche; Séverine Vermeire; Paul Rutgeerts
Journal:  Curr Opin Gastroenterol       Date:  2005-07       Impact factor: 3.287

4.  Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab.

Authors:  Maria Grazia Anelli; Diletta Domenica Torres; Carlo Manno; Crescenzio Scioscia; Florenzo Iannone; Michele Covelli; Francesco Paolo Schena; Giovanni Lapadula
Journal:  Arthritis Rheum       Date:  2005-08

5.  Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms.

Authors:  F Van den Bosch; E Kruithof; M De Vos; F De Keyser; H Mielants
Journal:  Lancet       Date:  2000-11-25       Impact factor: 79.321

6.  Long-term survival in systemic amyloid A amyloidosis complicating Crohn's disease.

Authors:  L B Lovat; S Madhoo; M B Pepys; P N Hawkins
Journal:  Gastroenterology       Date:  1997-04       Impact factor: 22.682

7.  Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial.

Authors:  Kristian Reich; Frank O Nestle; Kim Papp; Jean-Paul Ortonne; Robert Evans; Cynthia Guzzo; Shu Li; Lisa T Dooley; Christopher E M Griffiths
Journal:  Lancet       Date:  2005 Oct 15-21       Impact factor: 79.321
  7 in total
  2 in total

Review 1.  Small bowel amyloidosis.

Authors:  Milena Gould; Neda Zarrin-Khameh; Joseph Sellin
Journal:  Curr Gastroenterol Rep       Date:  2013-10

Review 2.  Management of cutaneous disorders related to inflammatory bowel disease.

Authors:  Zaira Pellicer; Jesus Manuel Santiago; Alejandro Rodriguez; Vicent Alonso; Rosario Antón; Marta Maia Bosca
Journal:  Ann Gastroenterol       Date:  2012
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.